Cocrystal Pharma, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
13.8M
on 2026-06-30, from 10.2M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
1 of its filings are not read yet.
Cash
3.4 quarters
$7.0M on 2025-12-31 ÷ $2.0M a quarter of operating cash used, the average of four quarters. 10-K ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-07-31 | Private placement | not read | $0.9134 | $5.0M | 8-K ↗ |
| 2025-10-28 | Private placement | not read | $1.39 | $1.0M | 8-K ↗ |
| 2025-09-12 | Public offering | 2,764,710 | $1.70 | $4.7M | 424B5 ↗ |